Can therapy safely be reduced to 2 years for males with pediatric T-cell leukemia?
Based on St. Judes, DFCI, and BFM data, COG has recently decreased the length of therapy for males with B-Cell ALL. Can this be extrapolated to T-cell ALL as well?
Community PollStarted
Can total duration of therapy be decreased to 2 years for males with pediatric T-cell ALL?
7 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet Member
Pediatric Hematology/Oncology · Washington University School of Medicine
Answered on
It is an open research question and it cannot be assumed that T cell ALL would have the same outcome. Given that the salvage rate for relapse T cell ALL is so low, this should be addressed in a clinical trial.
Join for free or sign in to see the full answer